Breast Implant Lymphoma Lawsuit Filed Against Allergan Over Natrelle Silicone Implants
An Illinois woman has filed a product liability lawsuit over Natrelle silicone implants, alleging that Allergan and its Inamed subsidiary should have warned about the risk that women may develop a rare form of cancer in the tissue surrounding the implant, which is now known as breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL).
The complaint (PDF) was filed by Kimberly Commisso in the Superior Court of New Jersey on May 23, indicating that the manufacturers knew or should have known about the risk, yet withheld information from consumers and the medical community.
Commisso underwent reconstructive surgery in July 2015 after being diagnosed with breast cancer and undergoing a bilateral mastectomy. She was implanted with Allergan Natrelle 410 Highly Cohesive Silicone-Filled breast implants. However, just two years later, in May 2017, she noticed breast swelling, and a biopsy revealed that she had developed BIA-ALCL. In June 2017, the breast implant was removed, and it appears that resolved the illness.
Learn More About
Women may face a risk of Anaplastic Large Cell Lymphoma (ALCL) from certain breast implants.Learn More About this Lawsuit See If You Qualify Now >
According to the lawsuit, if Allergan had properly tested its products and provided warnings about the risk of breast implant lymphoma, Commisso and hundreds, or even thousands of women nationwide would not have contracted cancer.
“At the time the Allergan Breast Implants were placed into Kimberly Commisso’s body, she was not advised, nor did she have any independent knowledge, that the Allergan Breast Implants were anything other than safe, life-long products,” the lawsuit notes. “Nor was she advised that the product was associated and/or known to cause BIA-ALCL.”
Breast Implant Lymphoma Warnings
The FDA first released a report about case studies and epidemiological research that suggested there was a link between breast implants and anaplastic large-cell lymphoma (ALCL) in January 2011.
In 2017, the agency issued an updated statement about emerging information on the breast implant lymphoma problems, and a number of subsequent studies have confirmed that the breast implant ALCL cancer risk is real.
In June 2017, a month after Commisso was diagnosed with BIA-ALCL, a study published in the medical journal Plastic and Reconstructive Surgery suggested that certain textured breast implants may increase the risk of anaplastic large cell lymphoma anywhere from 10 to 14 times, when compared to smooth breast implants.
In March 2018, the FDA indicated that it was aware of more than 400 cases of breast implant-related cancer. As more information becomes public about the breast implant cancer cases, experts have warned that the number of cases reported will likely increase significantly.
As regulators and researchers worldwide continue to evaluate the specific cause of the breast implant lymphoma problems, other women are also raising serious questions about why certain products appear to be more likely to be associated with the development of cancer, and how manufacturers failed to address potential design defects earlier.
Product liability lawyers in the U.S. are now reviewing other potential breast implant cancer lawsuits against Allergan and other manufacturers, for women diagnosed with the ALCL in recent years.
LeslieFebruary 10, 2020 at 10:41 pm
I have these implants and I’m just now seeing all the warning and lawsuits involving them I filled out the form online and was immediately called however the fact that haven’t been diagnosed with that particular cancer or any I was told there’s nothing they need from me or can do for me and have no insight on what I should do. Wow I’m floored! I have had nothing but issue with them as far as pain [Show More]I have these implants and I’m just now seeing all the warning and lawsuits involving them I filled out the form online and was immediately called however the fact that haven’t been diagnosed with that particular cancer or any I was told there’s nothing they need from me or can do for me and have no insight on what I should do. Wow I’m floored! I have had nothing but issue with them as far as pain and what I thought was deflation and other symptoms that cause concerning questions on my part. With that being said I haven’t seems any kind of doctor in 2 years due the the fact I have no insurance because my husband lost his jobs of 10 years and had 4 heart attacks. I have lots of health issues I need checked out. So what if ? I mean really? You would think if there was actual concern for us women and our health and life there would be some kind of referral or something !!!!! Scary......
WendyDecember 29, 2019 at 7:45 pm
I would like to be proactive in having these implants removed. Please advise as to how one should go about handling this process.
TerrySeptember 20, 2019 at 12:40 am
It is criminal that the FDA has allowed to implant these toxic bags to women who are breast cancer survivors! Shame on them! The pain and suffering is real!
PennyAugust 13, 2019 at 6:15 pm
Is there a class action suit for the women who had a bilateral mastectomy and got the implants to cause lymphoma, and now are willingfully going back in to surgery. Even though no symptoms of the lymphoma, yet don't want to risk it?
LynnJuly 30, 2019 at 1:49 pm
I had textured implants removed them 4months ago. I had pain swelling and capsulation. My mri concluded that there was leakage around the implants and being they were textured implants they were a possible danger. That women have gotten rare cancer. I have all my documentation including original info from McGHAN silicone filled breast implants.
"*" indicates required fields
More Top Stories
A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.
A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to provide adequate warning about the risks of the thyroid eye disease drug.